The Korean Journal of Food And Nutrition (한국식품영양학회지)

The Korean Society of Food and Nutrition (한국식품영양학회)
권호 표지
DOI QR코드

DOI QR Code

Secretion of Inflammatory Cytokines by Aloe vera Extract in HepG2 Cells

HepG2 세포에서 알로에 베라 추출물에 의한 염증성 사이토카인 분비

  • 김일낭 (울산과학대학교 식품영양과)
  • Received : 2014.04.30
  • Accepted : 2014.05.30
  • Published : 2014.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Recently, cases of Aloe vera induced-toxic hepatitis have been reported. However, the precise inflammatory effects of Aloe vera extract have not been clearly elucidated yet. In this study, the inflammatory effects and the mechanism of 70% ethanolic Aloe vera extract on liver were evaluated by in vitro assays using human hepatoma HepG2 cells. Cell viability was investigated using MTT assay at $0.001{\sim}100{\mu}g/mL$ of Aloe vera extract. To evaluate inflammatory effect of the Aloe vera extract, the secretion of pro-inflammatory cytokine Interleukin 8 (IL-8) and Macrophage colony-stimulating factor (M-CSF) were detected. Aloe vera extract did not induce cell death at concentrations of $0.001{\sim}100{\mu}g/mL$. However, Aloe vera extract significantly increased the IL-8 secretion by 15.7~25.8% and the M-CSF secretion by 36.6~61.5% at the same concentrations. These results indicate that Aloe vera extract shows an inflammation-related mild hepatotoxicity than a severe toxicity such as cell death and this hepatitis is mediated by the secretion of inflammatory cytokine IL-8 and M-CSF.

최근 알로에 베라 섭취에 의한 독성 간염이 보고되고 있으나, 아직까지 알로에 베라의 간에 대한 염증 효과가 명확히 밝혀지지 않았다. 본 연구는 알로에 베라 에탄올 추출물이 간세포의 염증 발현에 미치는 영향과 그 기전을 밝히기 위해 수행되었다. $0.001{\sim}100{\mu}g/mL$의 알로에 베라 추출물을 HepG2 세포에 처리하여 MTT assay를 시행한 결과, 모든 농도에서 세포사멸이 유도되지 않았다. 그러나 모든 농도에서 알로에 베라 추출물은 염증성 사이토카인인 IL-8의 분비를 15.7~25.8%까지 유의적으로 증가시켰다(p<0.05). 또 다른 사이토카인인 M-CSF도 알로에 베라 추출물에 의해 36.3~61.5%까지 유의적으로 분비가 증가되었다(p<0.05). 본 연구 결과는 알로에 베라 추출물이 IL-8과 M-CSF와 같은 염증성 사이토카인 분비기전에 의해 간에 염증을 유발할 수 있음을 보여준다. 또한 알로에 추출물에 의해 유발될 수 있는 간염기전을 제시함으로써, 향후 수행될 추가 실험을 위한 기초 자료로 그 가치가 높을 것으로 사료된다.

Keywords

References

  1. Bottenberg MM, Wall GC, Harvey RL, Habib S. 2007. Oral Aloe vera-induced hepatitis. Ann Pharmacother 41:1740-1743 https://doi.org/10.1345/aph.1K132
  2. Brusick D, Mengs U. 1997. Assessment of the genotoxic risk from laxative senna products. Environ Mol Mutagen 29:1-9 https://doi.org/10.1002/(SICI)1098-2280(1997)29:1<1::AID-EM1>3.0.CO;2-J
  3. Curciarello J, De Ortuzar A, Borzi S, Bosia D. 2008. Severe acute hepatitis associated with intake of Aloe vera tea. Gastroenterol Hepatol 31:436-438 https://doi.org/10.1157/13125590
  4. Elewa H, Abd-Elmeneem M, Hashem AM, Alshehaby A. 2010. Study of interleukin 8 (IL8) serum level in patients with chronic liver disease due to hepatitis C virus (HCV) with and without hepatocellular carcinoma (HCC). Int J of Hepatol 1:9-17
  5. Elizondo G, Medina-Diaz IM. 2003. Induction of CYP3A4 by 1alpha,25-dyhydroxyvitamin $D_3$ in HepG2 cells. Life Sci 73:141-149 https://doi.org/10.1016/S0024-3205(03)00262-5
  6. Gomez-Lechon MJ, Donato T, Ponsoda X, Castell JV. 2003. Human hepatic cell cultures: In vitro and in vivo drug metabolism. Altern Lab Anim 31:257-265
  7. Gomez-Quiroz L, Bucio L, Souza V, Escobar C, Farfan B, Hernandez E, Konigsberg M, Vargas-Vorackova F, Kershenobich D, Gutierrez-Ruiz MC. 2003. Interleukin 8 response and oxidative stress in HepG2 cells treated with ethanol, acetaldehyde or lipopolysaccharide. Hepatol Res 26:134-141 https://doi.org/10.1016/S1386-6346(03)00010-X
  8. Grimminger W, Witthohn K. 1993. Analytics of senna drugs with regard to the toxicological discussion of anthranoids. Pharmacology 47:98-109
  9. Grindlay D, Reynolds T. 1986. The Aloe vera phenomenon: a review of the properties and modern uses of the leaf parenchyma gel. J Ethnopharmacol 16:117-151 https://doi.org/10.1016/0378-8741(86)90085-1
  10. Gutierrez-Ruiz MC, Gomez Quiroz LE, Hernandez E, Bucio L, Souza V, Llorente L, Kershenobich D. 2001. Cytokine response and oxidative stress produced by ethanol, acetaldehyde and endotoxin treatment in HepG2 cells. Isr Med Assoc J 3:131-136
  11. Huang YS, Hwang SJ, Chan CY, Wu JC, Chao Y, Chang FY, Lee SD. 1999. Serum levels of cytokines in hepatitis Crelated liver disease: a longitudinal study. Zhonghua Yi Xue Za Zhi 62:327-333
  12. Itoh Y, Okanoue T, Enjyo F, Sakamoto S, Ohmoto Y, Hirai Y, Kagawa K, Kashima K. 1994. Serum levels of macrophage colony stimulating factor (M-CSF) in liver disease. J Hepatol 21:527-535 https://doi.org/10.1016/S0168-8278(94)80097-9
  13. Jennen DG, Magkoufopoulou C, Ketelslegers HB, van Herwijnen MH, Kleinjans JC, van Delft JH. 2010. Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci 115:66-79 https://doi.org/10.1093/toxsci/kfq026
  14. Kanat O, Ozet A, Ataergin S. 2006. Aloe vera-induced acute toxic hepatitis in healthy young man. Eur J Intern Med 17:589 https://doi.org/10.1016/j.ejim.2006.04.017
  15. Kluge M, Knapp I, Kramer D, Schwerdtner I, Ritter H. 1979. Crassulacean acid metabolism (CAM) in leaves of Aloe arborescens Mill: Comparative studies of the carbon metabolism of chlorenchym and central hydrenchym. Planta 145:357-363 https://doi.org/10.1007/BF00388361
  16. Lee HY, Suh SC. 2002. Physicochemical properties of aloe added bagel. Korean J Food and Nutr 15:209-214
  17. Luyendyk JP, Maddox JF, Cosma GN, Ganey PE, Cockerell GL, Roth RA. 2003. Ranitidine treatment during a modest inflammatory response precipitates idiosyncrasy-like liver injury in rats. J Pharmacol Exp Ther 307:9-16 https://doi.org/10.1124/jpet.103.054288
  18. Muller SO, Eckert I, Lutz WK, Stopper H. 1996. Genotoxicity of the laxative drug components emodin, aloe- emodin and danthron in mammalian cells: Topoisomerase II mediated?. Mutat Res 371:165-173 https://doi.org/10.1016/S0165-1218(96)90105-6
  19. O'Brien PJ, Irwin W, Diaz D, Howard-Cofield E, Krejsa CM, Slaughter MR, Gao B, Kaludercic N, Angeline A, Bernardi P, Brain P, Hougham C. 2006. High concordance of druginduced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch Toxicol 80:580-604 https://doi.org/10.1007/s00204-006-0091-3
  20. Olsavsky KM, Page JL, Johnson MC, Zarbl H, Strom SC, Omiecinski CJ. 2007. Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues. Toxicol Appl Pharmacol 222:42-56 https://doi.org/10.1016/j.taap.2007.03.032
  21. Park CS, Shin YS, Ryu IW, Lee KS. 2000. Antimicrobial activity of extracts from Aloe vera peel against Streptococcus mutans JC-2(I). Korean J Food and Nutr 13:139-145
  22. Parkinson A, Mudra DR, Johnson C, Dwyer A, Carroll KM. 2004. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmaco 199:193-209 https://doi.org/10.1016/j.taap.2004.01.010
  23. Rabe C, Musch A, Schirmacher P, Kruis W, Hoffmann R. 2005. Acute hepatitis induced by an Aloe vera preparation: A case report. World J Gastroenterol 11:303-304 https://doi.org/10.3748/wjg.v11.i2.303
  24. Reynolds T, Dweek AC. 1999. Aloe vera leaf gel: A review update. J Ethnopharmacol 68:3-37 https://doi.org/10.1016/S0378-8741(99)00085-9
  25. Reynolds T. 2005. Hemlock alkaloids from Socrates to poison aloes. Phytochemistry 66:1399-1406 https://doi.org/10.1016/j.phytochem.2005.04.039
  26. Russwurm S. Stonans I, Stonane E, Weigand G, Wiederhold M, Jager L, Reinhart K. 1998. HepG2 hepatocytes express IFN-${\gamma},\;TNF-{\alpha},\;TGF-{\beta}$, M-CSF, oncostatin-M, ICAM-1, IL-4, IL-5, IL-7, IL-10, IL-11, IL-12 and IL-6 receptor genes in vitro. Crit Care 2:P005
  27. Shin DH, Kim DW, Jeoung YM. 2007. Quality characteristics of bread with added aloe (Aloe vera Linne). Korean J Food and Nutr 20:399-405
  28. Skett P, Tyson C, Guillouzo A, Maier P. 1995. Report on the international workshop on the use of human in vitro liver preparations to study drug metabolism in drug development. Biochem Pharmacol 50:280-285 https://doi.org/10.1016/0006-2952(95)90011-X
  29. Son SM, Park JK. 2004. Study on the classification of health food circulated in the market. J Korean Dietetic Assoc 10:58-64
  30. Stonans I, Stonane E, Russwurm S, Deigner HP, Bohm KJ, Wiederhold M, Jager L, Reinhart K. 1999. HepG2 human hepatoma cells express multiple cytokine genes. Cytokine 11:151-156 https://doi.org/10.1006/cyto.1998.0366
  31. Watkins PB, Seeff LB. 2006. Drug-induced liver injury: Summary of a single topic clinical research conference. Hepatology 43:618-631 https://doi.org/10.1002/hep.21095
  32. Westerink WM, Schoonen WG. 2007. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Toxicol In Vitro 21:1581-1591 https://doi.org/10.1016/j.tiv.2007.05.014
  33. Yang HN, Kim DJ, Kim YM, Kim BH, Sohn KM, Choi MJ, Choi YH. 2010. Aloe-induced toxic hepatitis. J Korean Med Sci 25:492-495 https://doi.org/10.3346/jkms.2010.25.3.492
  34. Zimmermann HW, Seidler S, Gassler N, Nattermann J, Luedde T, Trautwein C, Tacke F. 2011. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS One 6:e21381 https://doi.org/10.1371/journal.pone.0021381
  35. National Institute of Food and Drug Safety Evaluation. 2011. Collection and Safety Management of the Adverse Events for Health/Functional Foods. pp. 15
  36. Ministry of Food and Drug Safety. 2014. Health Functional Foods. Available from http:// www.foodnara.go.kr/hfoodi/ [cited 2014 April 30]